This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Neglected Tropical Disease Treatment Market

Neglected Tropical Disease Treatment Market By Drug Class (Anti-Parasite, Antifungal, Antibiotics), Disease (Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis), Distribution Channel (Direct Sales, Indirect Sales) & Region - Forecast 2022-2032

Market Insights on Neglected Tropical Disease Treatment covering sales outlook, demand forecast & up-to-date key trends

Neglected Tropical Disease Treatment Market Overview

The global neglected tropical disease treatment market size is expected to reach US$ 7.9 Billion in 2032 and exhibit growth at a CAGR of 4.3% in the forecast period from 2022 to 2032. The market is set to be valued at US$ 3.4 Billion in 2022. The rising launch of various innovative programs by governments to tackle these diseases is set to propel the sales of neglected tropical disease treatment products in the upcoming years.

Report Attribute

Details

Neglected Tropical Disease Treatment Market Estimated Base Year Value (2021)

US$ 2.1 Billion

Neglected Tropical Disease Treatment Market Expected Market Value (2022)

US$ 3.4 Billion

Neglected Tropical Disease Treatment Market Anticipated Forecast Value (2032)

US$ 7.9 Billion

Neglected Tropical Disease Treatment Market Projected Growth Rate (2022-2032)

4.3% CAGR

Neglected tropical diseases are a group of poverty-promoting, debilitating, and chronic bacterial, parasitic, fungal, and some viral infections. These are mainly prevalent among the poorest people residing in emerging economies.

The elimination and control of these diseases has currently become a priority for achieving targets to reduce sustainable poverty and to attain the United Nations Millennium Development Goals (MDGs).

While drug treatments are available for these diseases, they don’t often reach people who are in need. Thus, many non-governmental and governmental organizations are striving to provide innovative drugs and enhance the healthcare infrastructure in regions where these diseases are the most prevalent.

Several drug manufacturing companies are also donating state-of-the-art medicines to help with the treatment of neglected tropical diseases. Some of the available treatments do not require the presence of healthcare professionals and are easy to administer.

Which are Some Prominent Drivers Spearheading Neglected Tropical Disease Treatment Market Growth?

The rising prevalence of neglected tropical diseases in emerging countries owing to multiple factors, such as the absence of proper hygiene maintenance and shortage of basic services including clean water is estimated to boost the global neglected tropical disease treatment market growth. The increasing usage of antiparasitic drugs, antiviral drugs, and antibacterial drugs for the treatment of Chagas disease, African sleeping sickness, Buruli ulcer, and leishmaniasis is another vital factor that is projected to drive the market.

Government bodies of various countries are consistently creating awareness among people regarding the availability of medicines for the treatment of these diseases. They are aiming to encourage people to practice better health practices in their everyday lives. Numerous companies across the globe are consistently investing huge sums in research and development activities to create new treatment options.  

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Neglected Tropical Disease Treatment Industry?

As neglected tropical diseases occur in poor parts of countries, the lack of awareness among people may decline sales of neglected tropical disease treatment options. The lack of access to cutting-edge medications and the presence of an underdeveloped healthcare infrastructure in these countries are a couple of other factors that may obstruct the growth in this market.

Why is Asia Pacific Emerging as an Opportunistic Neglected Tropical Disease Treatment Market?

Asia Pacific is expected to remain at the forefront in future years by generating the largest neglected tropical disease treatment market share. This growth is attributable to the presence of a huge target population and the rising GDP rate in India and China.

The increasing prevalence of neglected tropical diseases, such as trichuriasis, rabies, hookworm infection, visceral leishmaniasis, dengue fever, and ascariasis in these developing countries is another significant factor that is projected to bode well for the regional market. The Indian government, for instance, has collaborated with the World Health Organization (WHO) to make financial investments in healthcare to eliminate and reduce cases of such diseases.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Latin America Contributing to Growth of the Neglected Tropical Disease Treatment Market?

The increasing untapped potential for the treatment of patients suffering from neglected tropical diseases in Brazil and Mexico is anticipated to augur well for the Latin America market. The rising number of awareness programs conducted by governments of these countries is also set to push the demand for neglected tropical disease treatment options in Latin America.

As per a study published in the National Library of Medicine, nearly 40% of the projected 556 million people living in the Caribbean and Latin American region are below the poverty line. It includes 74 million people who live on less than US$ 2 per day and 47 million people that live on less than US$ 1 per day. These numbers are expected to grow at a rapid pace in the forthcoming years, thereby propelling the regional market.

Market Competition

Some of the leading companies present in the global neglected tropical disease treatment market include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Omega Diagnostics Group PLC, Abbott, Oscar Medicare Pvt Ltd., Genome Diagnostics Pvt. Ltd., and ZeptoMetrix among others.

Majority of the key players operating in the global market are increasingly focusing on partnerships, collaborations, and new product development to strengthen their positions. Meanwhile, a few other companies are aiming to gain fast track approvals from regulatory bodies, such as the U.S. FDA to distribute and market their products.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 4.3% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Drug Class
  • Disease Type
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Omega Diagnostics Group PLC
  • Abbott
  • Oscar Medicare Pvt Ltd.
  • Genome Diagnostics Pvt. Ltd.
  • ZeptoMetrix

Customization

Available Upon Request

Key Segments Profiled in the Neglected Tropical Disease Treatment Industry Survey

By Drug Class:

  • Anti-Parasite
  • Antifungal
  • Antibiotics
  • Others

By Disease Type:

  • Leishmaniasis
  • Schistosomiasis
  • Lymphatic Filariasis
  • Chagas Disease
  • African Trypanosomiasis
  • Others

By Distribution Channel:

  • Direct Sales
  • Indirect Sales

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Frequently Asked Questions

The global neglected tropical disease treatment market is set to exceed US$ 7.9 Billion in 2032.

Asia Pacific is expected to lead the neglected tropical disease treatment market in the forecast period.

Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Omega Diagnostics Group PLC, Abbott, and Oscar Medicare Pvt Ltd. are some of the renowned companies in the neglected tropical disease treatment market.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Neglected Tropical Disease Treatment Market